← Back
$LIXT All transactions

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

A

$ Value

$0

Shares

350,000

Price

$0

Filed

Jul 9

Insider

Name

Pursglove Geordan Garrett

Title

CEO and Chairman of the Board

CIK

0002073519

Roles

Director Officer

Transaction Details

Transaction Date

2025-07-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

350,000

Footnotes

Effective July 3, 2025, the reporting person was granted stock options to purchase an aggregate of 350,000 shares vesting 50% on the effective date, 25% on September 30,2025 and 25% on December 31,2025. The grant was a signing bonus for the reporting person entering into an employment agreement with the issuer. The exercise price is $2.83 per share.

Filing Info

Accession No.

0001641172-25-018489

Form Type

4

Issuer CIK

0001335105

Pursglove Geordan Garrett's History

Date Ticker Type Value
2026-04-15 LIXT A
2026-04-15 LIXT D
2026-01-01 GRDX A $0
2025-07-03 LIXT A $0

Other Insiders at LIXT (90d)

Insider Bought Sold Last
Felix Lourdes 2026-04-15
Pursglove Geordan Garrett
CEO and Chairman of the Board
2026-04-15
Sawyer Jason David 2026-04-15
Holloway Michael Andrew 2026-04-15
Stazzone Peter
Chief Financial Officer
2026-04-15
Primus Guy Warren 2026-04-15